Navigation Links
Transgenomic, Inc. Presentations to Describe High-Sensitivity Detection of Cancer Biomarkers at the 2011 American Association for Cancer Research Meeting
Date:4/1/2011

ized medicine. We are rapidly developing Ice COLD-PCR and BLOCker-Sequencing assays for important cancer genes such as EGFR, K-RAS, PIK3CA, BRAF, NRAS and TP53, and, in fact, most of these assays are already being offered to our pharmaceutical company partners through our Pharmacogenomics services laboratory in support of their clinical trial studies. Our next goal is to offer BLOCker-Sequencing assay kits for laboratories to test tumor tissue directly with a high mutation detection rate and to combine Ice COLD-PCR and BLOCker-Sequencing in kits for testing these same gene mutations in blood where the highest sensitivity is required. We believe that this combination of technologies is unique in the marketplace and will enable us to become a significant contributor in the molecular analysis and detection of cancer."

Transgenomic Presentations at AACR:

Development of a Sensitive COLD-PCR Method for the Detection of EGFR Mutations in DNA

Presenter: Katherine Richardson, Ph.D., Vice President of Research and Development

Abstract #3063. Tuesday, April 5, 8:00 AM - 12:00 PM

Use of Blocker Locked Nucleic Acid (LNA™) Oligonucleotides in Cycle Sequencing for Improved Limits of Detection (BLOCker™-Sequencing)

Presenter: Benjamin Legendre, Ph.D., Manager, Pharmacogenomics Laboratory Services

Abstract  #4855. Wednesday, April 6, 8:00 AM - 12:00 PM

About Transgenomic, Inc.

Transgenomic, Inc. (www.transgenomic.com) is a global biotechnology company specializing in high sensitivity genetic variation and mutation analysis, providing products and services in DNA mutation detection and discovery for clinical research, clinical molecular diagnostics and pharmacogenomics analyses. Product offerings include the WAVE&#
'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Transgenomic, Inc. Reports Third Quarter 2009 Results
2. Transgenomic, Inc. Reports Second Quarter 2009 Results
3. Transgenomic, Inc. Announces Appointment of New Board Members
4. Transgenomic, Inc. Reports First Quarter 2009 Results
5. Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results
6. Transgenomic, Inc. Reports Third Quarter 2008 Results
7. Dendreon Announces Webcast Presentations at Four Upcoming Conferences
8. Optimer Pharmaceuticals Announces Presentations at Upcoming IDSA Annual Meeting
9. Orexigen® Therapeutics Announces Upcoming Data Presentations at the 28th Annual Scientific Meeting of The Obesity Society
10. Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology (ASCO) Annual Meeting
11. Oncothyreon announces presentations at upcoming investor conferences in June
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015   SurePure, ... liquid photopurification, announced today that the Company has ... the continued trading of SurePure ("SURP") securities on ... marketplace for entrepreneurial and development stage companies. ... introduced standards and eligibility requirements designed to improve ...
(Date:3/27/2015)... Governor Andrew M. Cuomo today announced the ... the world’s largest business idea competition with $5 million ... million, six $500,000 awards and four $250,000 awards. The ... for prizes that will turn ideas with high growth ... region. , "Last year's successful 43North competition brought ...
(Date:3/26/2015)... March 26, 2015  BioNano Genomics, Inc., the leader ... Salyer as chief commercial officer. Salyer has more ... sales teams in life sciences. At BioNano, Salyer will ... a genome-mapping platform to assemble a comprehensive view of ... To date, 32 institutions located in the ...
(Date:3/26/2015)... March 26, 2015 "In America," the popular ... United States that is hosted by legendary film actor James ... of botany in an upcoming segment. , Botany is ... reality it is actually quite a bit more complicated than ... different types of living organisms, from the smallest bacteria known ...
Breaking Biology Technology:SurePure Completes Verification and Approved for Trading on the OTCQB Marketplace 2Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 2Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 3Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 4Governor Andrew M. Cuomo Anounces Launch of Year Two of World's Largest Business Idea Competition and Opening of New Incubator Space in Buffalo, New York 5BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 2BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 3
... Nov. 12 VIA Pharmaceuticals,(Nasdaq: VIAP ... development of,compounds for the treatment of cardiovascular ... advisory board. Joining the clinical advisory,board,s chair, ... Medicine,Harvard Medical School, and Senior Physician, Brigham ...
... Conditions in Patients Who are Already Taking Opioid ... ... 12 Cephalon, Inc. (Nasdaq:,CEPH) today announced it has submitted a ... (FDA) seeking approval to,market FENTORA(R) (fentanyl buccal tablet) [C-II] for the ...
... The Edwin A. Stevens Society of Stevens Institute of Technology ... Systems and Enterprises, Dr. Dinesh Verma, with the Presidents Leadership ... Park Avenue Club in Florham Park, N.J., Nov. 10, beginning ... invitation only., The Presidents Leadership Award is presented to a ...
Cached Biology Technology:VIA Pharmaceuticals Expands Clinical Advisory Board With Leading Experts in Cardiovascular Disease 2VIA Pharmaceuticals Expands Clinical Advisory Board With Leading Experts in Cardiovascular Disease 3VIA Pharmaceuticals Expands Clinical Advisory Board With Leading Experts in Cardiovascular Disease 4Cephalon Submits Supplemental New Drug Application for FENTORA 2Cephalon Submits Supplemental New Drug Application for FENTORA 3Cephalon Submits Supplemental New Drug Application for FENTORA 4Cephalon Submits Supplemental New Drug Application for FENTORA 5Cephalon Submits Supplemental New Drug Application for FENTORA 6Cephalon Submits Supplemental New Drug Application for FENTORA 7Dr. Dinesh Verma to be honored with President's Leadership Award at Edwin A. Stevens Society Gala 2Dr. Dinesh Verma to be honored with President's Leadership Award at Edwin A. Stevens Society Gala 3
(Date:3/18/2015)... As mobile payments become more prevalent ... and apps continue to be introduced into the market place ... payment industry in focus today are:  NXT-ID, Inc. (NASDAQ: ... BABA ), Apple Inc. (NASDAQ: AAPL ), Google ... FB ) NXT-ID, Inc. (NASDAQ: ...
(Date:3/16/2015)... , March 16, 2015 ... GmbH will present groundbreaking innovations in biometric identification ... Germany .      (Photo: ... biometric innovation is well at the forefront: the ... e-gate made in Germany . ...
(Date:3/12/2015)... , March 12, 2015 WHEN:Tuesday, March ... Registration here: http://bit.ly/1G7Os0L . SPEAKERS: , Frost ... SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 Biometric ... to compete in several different markets and industries. ... currently witnessing an uptrend. Join ...
Breaking Biology News(10 mins):Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 2DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015 3Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3
... BOSTON--A section of the AIDS virus,s protein envelope once considered ... one of the most promising, new research by Dana-Farber Cancer ... protein known as the V3 loop, is an attractive vaccine ... offer protection against multiple genetic subtypes of HIV-1, the virus ...
... NEW YORK, March 31, 2011 Hoyos Group ... Chief Marketing Officer, effective April 1, 2011. ... a member of Hoyos Group,s senior executive team, ... marketing, strategic business development, brand strategy, positioning and ...
... small block of aluminum with a tiny groove carved ... Institute of Standards and Technology (NIST) and the Polytechnic ... "green chemistry" method for making biodegradable polymers. Their recently ... of microfluidics, a technology more commonly associated with inkjet ...
Cached Biology News:Study identifies promising target for AIDS vaccine 2Study identifies promising target for AIDS vaccine 3Hoyos Group Appoints Anthony Antolino as Chief Marketing Officer 2Hoyos Group Appoints Anthony Antolino as Chief Marketing Officer 3Microreactors: Small scale chemistry could lead to big improvements for biodegradable polymers 2
... Blunt-Ended PCR Cloning Kit, 40 reactions. ... cloning of all PCR products with ... cloning approaches by offering consistently better ... 25-fold more positive clones.Amplicons generated by ...
PCR System for increased fidelity, yield and length of PCR products. Amplifies targets up to 10 kb from human genomic DNA....
... Peptide sequences: Two separate vials ... to the same sequence used as ... (Catalog No. 160890) ... Cayman's guanylate cyclase polyclonal antiserum (Catalog ...
...
Biology Products: